Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Nephrology Dialysis Transplantation Reports Phase 2 Data of Investigational ... - Nasdaq PDF Print

Nephrology Dialysis Transplantation Reports Phase 2 Data of Investigational ...
Nasdaq
SAN FRANCISCO, Aug. 12, 2015 (GLOBE NEWSWIRE) -- FibroGen, Inc. (Nasdaq:FGEN), a research-based biopharmaceutical company, today announced that Nephrology Dialysis Transplantation has published encouraging Phase 2a safety and efficacy ...

and more »

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.